| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 511.25% | HC Wainwright & Co. | $5 → $2.5 | Maintains | Buy |
| 10/06/2023 | 266.75% | Piper Sandler | $2.5 → $1.5 | Maintains | Neutral |
| 08/10/2023 | 511.25% | Piper Sandler | $3 → $2.5 | Maintains | Neutral |
| 08/10/2023 | 1122.49% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/11/2023 | 1122.49% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 04/13/2023 | 1122.49% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 04/05/2023 | 878% | Raymond James | $5 → $4 | Maintains | Strong Buy |
| 03/15/2023 | 755.75% | B of A Securities | $2 → $3.5 | Upgrades | Underperform → Buy |
| 11/10/2022 | 1122.49% | Raymond James | $6 → $5 | Maintains | Strong Buy |
| 10/17/2022 | 755.75% | Piper Sandler | $4.5 → $3.5 | Maintains | Neutral |
| 07/19/2022 | 755.75% | Piper Sandler | $2 → $3.5 | Upgrades | Underweight → Neutral |
| 07/12/2022 | 1366.99% | Raymond James | $7 → $6 | Maintains | Strong Buy |
| 05/23/2022 | 1611.49% | Northland Capital Markets | → $7 | Initiates Coverage On | → Outperform |
| 05/12/2022 | 1366.99% | Credit Suisse | $8 → $6 | Maintains | Outperform |
| 05/11/2022 | 1611.49% | Raymond James | $10 → $7 | Maintains | Strong Buy |
| 04/21/2022 | 633.5% | Piper Sandler | $4 → $3 | Downgrades | Neutral → Underweight |
| 04/08/2022 | 878% | Piper Sandler | → $4 | Downgrades | Overweight → Neutral |
| 03/16/2022 | 1122.49% | B of A Securities | $4.5 → $5 | Maintains | Underperform |
| 03/16/2022 | 2344.99% | Raymond James | $12 → $10 | Maintains | Strong Buy |
| 01/20/2022 | 2344.99% | Credit Suisse | $18 → $10 | Maintains | Outperform |
| 01/14/2022 | 1122.49% | B of A Securities | $9 → $5 | Downgrades | Neutral → Underperform |
| 10/20/2021 | 2100.49% | Barclays | $11 → $9 | Upgrades | Equal-Weight → Overweight |
| 10/05/2021 | 2833.99% | Raymond James | $15 → $12 | Maintains | Strong Buy |
| 06/10/2021 | 3567.48% | Piper Sandler | → $15 | Initiates Coverage On | → Overweight |
| 05/24/2021 | 3567.48% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 05/24/2021 | 3078.48% | UBS | → $13 | Initiates Coverage On | → Buy |
| 05/24/2021 | 3078.48% | Raymond James | → $13 | Initiates Coverage On | → Strong Buy |
| 05/24/2021 | 2833.99% | B of A Securities | → $12 | Initiates Coverage On | → Buy |
| 05/24/2021 | 5523.47% | Credit Suisse | → $23 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 2589.49% | Barclays | → $11 | Initiates Coverage On | → Equal-Weight |
| 05/24/2021 | 3078.48% | Cowen & Co. | → $13 | Initiates Coverage On | → Outperform |
What is the target price for FTC Solar (FTCI)?
The latest price target for FTC Solar (NASDAQ: FTCI) was reported by HC Wainwright & Co. on November 9, 2023. The analyst firm set a price target for $2.50 expecting FTCI to rise to within 12 months (a possible 511.25% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for FTC Solar (FTCI)?
The latest analyst rating for FTC Solar (NASDAQ: FTCI) was provided by HC Wainwright & Co., and FTC Solar maintained their buy rating.
When is the next analyst rating going to be posted or updated for FTC Solar (FTCI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FTC Solar, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FTC Solar was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating FTC Solar (FTCI) correct?
While ratings are subjective and will change, the latest FTC Solar (FTCI) rating was a maintained with a price target of $5.00 to $2.50. The current price FTC Solar (FTCI) is trading at is $0.41, which is out of the analyst's predicted range.